Nuclear Medicine

'Hype' is over for PET/MRI, experts say
PET/MRI has entered the "Slope of Enlightenment" phase of the Gartner Hype Cycle, according to experts.
September 26, 2023
The Gartner Hype Cycle
Rare finding detected on PSMA-PET: A nonprostatic lung tumor
A group in Australia has described a rare finding during a prostate cancer restaging PET/CT scan – a pulmonary tumor embolism.
September 25, 2023
Hybrid contrast-enhanced CT (with iodinated contrast bolus timed to maximize pulmonary arterial visualization) and F-18 DCFPyL PSMA-PET images. Contrast CT images (A, B) show an eccentric filling defect in the superior lingula segmental artery of the left lung upper lobe (red arrow). This is concordant with moderately intense PSMA radiotracer expression (black arrows on axial PET-only images, C, and on whole-body maximum intensity projection image, E). Fused PET and contrast-enhanced CT axial image (D) also confirm the lesion (red arrow). No other site of PSMA expressing metastasis is evident on whole-body imaging (E).
Is Pylarify better than Ga-68 PSMA-11 for prostate cancer imaging?
Subtle differences in how PSMA-PET radiotracers perform in patients before Pluvicto treatment may determine which become the future tracers of choice.
September 22, 2023
PSMA-PET imaging
ADNI aims to increase diversity in clinical trials.
The Alzheimer's Disease Neuroimaging Initiative (ADNI) has launched its latest study with a focus on enrolling a more diverse population.
September 15, 2023
Am 2022 01 12 18 18 1479 Patient Elderly Confused Headache 400
Can ChatGPT help prepare patients for PET scans?
ChatGPT can substitute for staff advice given to patients about PET/CT scans, according to a group in Germany.
September 14, 2023
Chat Gpt Artificial Intelligence Ai Head 400
MITA asks CMS to improve radiopharmaceutical coverage
The Medical Imaging and Technology Alliance (MITA) has raised concerns over a proposed 2024 Medicare rule.
September 13, 2023
Washington Dc Capitol Social
New PET tracer shows promise visualizing cardiac amyloidosis
A team at Harvard University in Cambridge, MA, has tested the first PET radiotracer specifically for visualizing cardiac amyloidosis, also known as "stiff heart syndrome," according to a recent study.
September 12, 2023
2016 12 01 17 10 35 256 Pulmonary Trunk Heart 400
Dual-targeting PET tracer begins to show its stripes
New evidence suggests that PET/CT imaging with a gallium-68 (Ga-68)-labeled heterodimeric radiotracer is highly effective for visualizing various types of malignant cancer, according to a group in China.
September 12, 2023
2023 09 12 21 01 4070 2023 09 13 Lnc1007
PET imaging predicts long-term outcomes in Parkinson's disease
PET brain imaging in individuals with early Parkinson's disease can show which patients are at higher risk of long-term effects, according to a study by researchers in Italy.
September 11, 2023
2021 06 09 23 42 6597 Parkinsons Torn Newspaper 400
FAPI-PET/CT may improve treatment of cancer patients
Gallium-68 (Ga-68) FAPI-PET/CT imaging -- a highly accurate experimental approach for detecting cancer -- may further improve outcomes for patients undergoing radiation therapy, according to a recent analysis by German researchers.
September 11, 2023
2023 09 11 22 52 0346 2023 09 11 Fapi 20230911224724
Eczacıbaşı-Monrol to expand Lu-177 production
Turkish radiopharmaceutical company Eczacıbaşı-Monrol plans to expand its Lutetium-177 (Lu-177) production capacity.
September 10, 2023
2017 08 16 13 40 50 749 Graph Arrow Up 400
PET/CT-based model predicts prostate cancer in the 'PSA grey zone'
Combining PET/CT with traditional clinical risk factors can detect prostate cancer in cases considered borderline based on prostate-specific antigen (PSA) levels -- in other words, cases in the "PSA grey zone," according to a group in Hunan, China.
September 10, 2023
2023 09 08 15 10 4007 2023 09 08 Prostate Cancer 20230908154926
Page 1 of 434
Next Page